February 23, 2007

Gadd45a Wakes Sleeping Genes

For several years now, cancer researchers have been studying a mechanism that contributes to the development of malignant tumors: The cell attaches small molecules containing a carbon atom, called methyl groups, to specific building blocks of DNA, thereby individually switching off the genes thus labeled. This silencing also affects the function of many tumor suppressor genes, which, in their unmethylated state, put the brakes on uncontrolled cell growth. In contrast to 'real' mutations, where DNA building blocks are exchanged or lost, these epigenetic changes are reversible. Therefore, this mechanism is considered to be a promising approach in fighting cancer.

The cell uses this mechanism of putting genes to sleep and waking them up again when needed for many regulation processes. Scientists have already found out how the methyl groups are attached. The reverse process of demethylation, however, has been poorly understood so far. Researchers from the divisions of Professor Dr. Christof Niehrs and Professor Dr. Frank Lyko at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have now been able to identify a protein called Gadd45a as a key player in demethylation. Gadd45a is a long known protein that is involved in many cellular processes.

The researchers showed in a series of experiments that an increase of Gadd45a levels in the cells wakes deactivated genes from their sleep. Control experiments showed that methyl groups are indeed no longer attached to genes thus reactivated. In contrast, if Gadd45a is deliberately switched off, hypermethylation of many DNA areas is the result. When removing the methyl groups, as the investigators have further demonstrated, Gadd45a interacts with enzymes that are involved in DNA repair. The data obtained by Niehrs and Lyko indicate that Gadd45a induces DNA-cutting enzymes of the DNA repair troops to remove the methylated areas, which are subsequently replaced again by unmethylated building blocks.

"The role of Gadd45a for cancer development is shown in mice lacking this protein," Niehrs und Lyko explained. "These animals suffer particularly often from malignant tumors. Now we are able to make sense of this: The knockdown of Gadd45a in these animals causes excessive methylation of tumor suppressor genes so that many of the natural tumor 'brakes' fail to work. Therefore, Gadd45a may also become an interesting target for clinical oncology."

The task of the Deutsches Krebsforschungszentrum in Heidelberg (German Cancer Research Center, DKFZ) is to systematically investigate the mechanisms of cancer development and to identify cancer risk factors. The results of this basic research are expected to lead to new approaches in the prevention, diagnosis and treatment of cancer. The Center is financed to 90 percent by the Federal Ministry of Education and Research and to 10 percent by the State of Baden-Wuerttemberg. It is a member of the Helmholtz Association of National Research Centers (Helmholtz-Gemeinschaft Deutscher Forschungszentren e.V.).

About DEUTSCHES KREBSFORSCHUNGSZENTRUM

Deutsches Krebsforschungszentrum (DKFZ) Heidelberg was founded as a non-profit organization and supraregional research center by the Land (state) Baden-Wuerttemberg in 1964. It was constituted as a foundation of public law. Since 1975, it has been a GroŠ“ŃŸforschungseinrichtung (National Research Center). It is mainly funded by the Bundesforschungsministerium (Federal Ministry for Research and Technology) (90 %) and by the Ministerium fuer Forschung und Wissenschaft (Ministry for Research and Sciences) of the Land Baden-Wuerttemberg (10 %). Additional funding is obtained by other public and private sources e.g. the Deutsche Forschungsgemeinschaft (German Science Association), special projects of the European Union (EU), of Federal and State ministries as well as cooperations with the industry and also private donations to the foundation. In accordance with its Statutes and Articles, it is the task of the Center to engage in cancer research. "Cancer research", a term which every discipline defines quite differently. In a center with a multi-disciplinary structure, the discussion about the research program is a continuous balancing process.

DEUTSCHES KREBSFORSCHUNGSZENTRUM
Im Neuenheimer Feld 280
69120 Heidelberg
http://www.dkfz.de/

No comments: